Previous 10 | Next 10 |
BOSTON, Aug. 04, 2022 (GLOBE NEWSWIRE) -- Yumanity Therapeutics, Inc. (“Yumanity” or the “Company”) (Nasdaq: YMTX), a clinical-stage biopharmaceutical company focused on the discovery and development of innovative, disease-modifying therapies for neurodegenerativ...
Gainers: Mirati Therapeutics (MRTX) +23%. CymaBay Therapeutics (CBAY) +16%. Veru (VERU) +9%. Kodiak Sciences (KOD) +8%. Allarity Therapeutics (ALLR) +7%. Losers: Verastem (VSTM) -12%. Delcath Systems (DCTH) -11%. Vicarious Surgical (RBOT) -8%. CEL-...
Target (TGT) -8% after warning on hit to margins from clearing inventory. FLEX LNG (FLNG) -7%. Globus Maritime (GLBS) -7% on Q1 earnings release. Yumanity Therapeutics (YMTX) -6%. AeroClean Technologies (AERC) -7%. FTC Solar (FTCI) -5%. Coupa Software (COUP) -4% ...
3 Penny Stocks That Exploded During Trading Today If you’re looking for the best penny stocks to buy, there are plenty of options to choose from. But, investors need to make sure that the companies on their lists, are penny stocks that are worth investing in. Here are a few t...
Gainers: Aero Clean Technologies (AERC) +58%. DiDi Global (DIDI) +39%. Yumanity Therapeutics (YMTX) +31%. Pineapple Energy (PEGY) +25%. View (VIEW) +26%. ATIF Holdings (ATIF) +26%. The Arena Group Holdings (AREN) +25%. Cerberus Cyber Sentinel (CISO) +23%. FTC Solar (FTCI) +23%. Kanzhun (BZ) +...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips WWDC 2022 starts today with a keynote presentation. Apple is expected to show off iOS updates today. We may also get a look at its AR plans. Source: Vytautas Kielaitis / Shutterstock.com WWDC 2022 kicks off to...
Gainers: Yumanity Therapeutics YMTX +46%. Babylon (BBLN) +11%. Sema4 (SMFR) +11%. Nano-X Imaging (NNOX) +10%. Satsuma Pharmaceuticals (STSA) +10%. Losers: Praxis Precision Medicines PRAX -63%. eFFECTOR Therapeutics (EFTR) -20%. Pear Therapeutics (PEAR) ...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips DiDi Global (NYSE: DIDI ) leads our gainers on probe reports. Amazon (NASDAQ: AMZN ) tops the losers as its stock splits. Plenty of other shares are rising and falling this morning. Source: Shutterstoc...
Yumanity Therapeutics (NASDAQ:YMTX) is selling its lead clinical-stage product YTX-7739 to Johnson & Johnson (NYSE:JNJ) for $26M in cash and is merging with privately-held Kineta in an all-stock transaction. Yumanity said it is selling YTX-7739 and its unpartnered disc...
Yumanity Therapeutics, Inc. to sell its clinical-stage product candidate YTX-7739 as well as its unpartnered discovery-stage neuroscience product candidates and targets to Janssen Pharmaceutica NV in a $26 million cash transaction Kineta, Inc., a private immuno-oncology company,...